AGP Executive Report
Last update: 3 hours agoAutism/ADHD Screening Breakthrough: A 17-year-old New Jersey student, Edward Kang, won major recognition for RetinaMind, an AI tool that screens for autism spectrum disorder and ADHD using retinal images. Opioid Treatment Access: A Rutgers study finds long-acting injectable buprenorphine use in New Jersey rose to nearly 5% of prescriptions, up from 0.7%, as researchers argue the monthly shots can help prevent overdoses for people who struggle with daily meds. Youth Social Media Lawsuit: Four states including New Jersey are seeking up to $1.4 trillion in penalties from Meta over claims Facebook/Instagram were designed to addict children. FDA Manufacturing Push: The FDA selected seven companies for its PreCheck Pilot Program to speed feedback on new U.S. drug manufacturing sites. NJ Health Alert—“Diarrhea Bug”: Cyclosporiasis cases tied to Cyclospora are rising, with officials still working to identify the source in New Jersey and across the U.S. Public Health & Safety: A serious crash on I-78 in Bedminster sent a motorcyclist to Robert Wood Johnson University Hospital after a helicopter response.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
